FGFR3 mutations and medial temporal lobe dysgenesis

Journal of Child Neurology

Volumn 22, Issue 2, 2007, Pages 211-213

  Kannu, Peter ^a   Aftimos, Salim ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b Northern Regional Genetics Service   (New Zealand)

Author keywords

Achondroplasia; FGFR3; Hypochondroplasia; Neuroimaging; Thanatophoric dysplasia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ARTICLE; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CASE REPORT; CENTRAL NERVOUS SYSTEM MALFORMATION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; EPILEPSY; GENE MUTATION; HIPPOCAMPUS; HUMAN; HYPOCHONDROPLASIA; MALE; NEUROIMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL LOBE;

ASPARAGINE; CHILD, PRESCHOOL; HUMANS; LYSINE; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; OSTEOCHONDRODYSPLASIAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; TEMPORAL LOBE;

EID: 34249850200     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807300292     Document Type: Article

References (12)

1. Grosso S., Farnetani MA, Berardi R., et al. Medial temporal lobe dysgenesis in Muenke syndrome and hypochondroplasia. Am J Med Genet. 2003; 120A: 88-91.
2. Kannu P., Hayes IM, Mandelstam S., et al. Medial temporal lobe dysgenesis in hypochondroplasia. Am J Med Geret. 2005; 138: 389-391.
3. Bellus GA, McIntosh I., Smith EA, et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet. 1995; 10: 357-359.
4. Prinos P., Costa T., Sommer A., Kilpatrick MW, Tsipouras P. A common FGFR3 gene mutation in hypochondroplasia. Hum Mol Genet. 1995; 4: 2097-2101.
5. Baird A. Fibroblast growth factors: Activities and significance of non-neurotrophic growth factors. Curr Opin Neurobiol. 1994; 4: 78-86.
6. Thompson LM, Plummer S., Schalling M., et al. A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics. 1991; 11: 1133-1142.
7. Bellus GA, Spector EB, Speiser PW, et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet. 2000; 67: 1411-1421.
8. van Rhijn BW, van Tilborg AA, Lurkin I., et al. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. Eur J Hum Genet. 2002; 10: 819-824.
9. Jungnickel J., Gransalke K., Timmer M., Grothe C. Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system. Mol Cell Neurosci. 2004; 25: 21-29.
10. Lu L., Airey DC, Williams RW Complex trait analysis of the hippocampus: mapping and biometric analysis of two novel gene loci with specific effects on hippocampal structure in mice. J Neurosci. 2001; 15: 3503-3514.
11. Hall BD, Spranger J. Hypochondroplasia: Clinical and radiological aspects in 39 cases. Radiology. 1979; 133: 95-100.
12. Lin T., Sandusky SB, Xue H., et al. A central nervous system specific mouse model for thanatophoric dysplasia type II. Hum Mol Genet. 2003; 12: 2863-2871.